Loading... Please wait...

Blog - FDA Regulations

FDA Finally Addresses Synthetic Nicotine; Confirming Next Generation Labs’ Position that Synthetic Nicotine Is Not A Tobacco Product

Posted

TFN Nicotine® – a non-tobacco derived synthetic nicotine – is pleased to report an update from the FDA that finally addresses the question of synthetic nicotine, confirming that e-liquids made with synthetic nicotine will not be regulated.

The FDA is slowly revealing its stance on regulating synthetic nicotine and while this latest update is a welcome one, we fully anticipate further clarification from the FDA as the August PMTA deadline approaches. All indications from the FDA confirm our long-held position: TFN Nicotine products cannot be regulated under the Deeming Rule as they are not tobacco products, and we continue to believe that an open or closed system device for use with a choice of synthetic nicotine products will qualify as a non-tobacco product.” 

Vincent Schuman, CEO of Next Generation Labs, comments: “The FDA is slowly revealing its stance on regulating synthetic nicotine and while this latest update is a welcome one, we fully anticipate further clarification from the FDA as the August PMTA deadline approaches. All indications from the FDA confirm our long-held position: TFN Nicotine products cannot be regulated under the Deeming Rule as they are not tobacco products, and we continue to believe that an open or closed system device for use with a choice of synthetic nicotine products will qualify as a non-tobacco product.”

It’s possible that a disposable, closed system device that contains an e-liquid with truly zero nicotine (or synthetic nicotine) would not be regulated by the FDA as a tobacco product, if it is not intended or reasonably be expected to be used in such a fashion.” The statement reaffirms the FDA’s position that a ‘tobacco product’ is defined as “any product made or derived from tobacco, including any component, part, or accessory of a tobacco product.”

The FDA is starting to develop its thinking on synthetic nicotine, making this a critical time for e-liquid manufacturers to enter the market with a synthetic nicotine product. As FDA clarifications emerge, Next Generation Labs will strive to protect the synthetic nicotine market, offering practical solutions to any requirements that may develop between now and August 2017,” concludes Schuman." 

The FDA is starting to develop its thinking on synthetic nicotine, making this a critical time for e-liquid manufacturers to enter the market with a synthetic nicotine product. As FDA clarifications emerge, Next Generation Labs will strive to protect the synthetic nicotine market, offering practical solutions to any requirements that may develop between now and August 2017,” concludes Schuman.


Next Generation Labs sells TFN Nicotine directly to e-liquid manufacturers. To purchase TFN Nicotine, please contact Vincent Schuman at Vincent@nextgenerationlabs.com.

About Next Generation Labs
Founded in 2014, Next Generation Labs developed TFN Nicotine®, the world’s leading synthetic nicotine that is not derived from tobacco. TFN Nicotine is used in over 40 e-liquid brands in the US and is playing a central role in revolutionizing the e-cigarette and vaping industry.
www.nextgenerationlabs.com

Original Post from Yahoo Finance:FDA Addresses Synthetic Nicotine




Betamorph E-Cigs

2000 Carlisle Blvd NE Suite B
Albuquerque, NM 87110
Get Directions
Email:service@betamorphecigs.com
Betamorph E-Cigs

Check us out on Facebook